Search Results 321-330 of 13317 for monoclonal antibody
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
Lecanemab belongs to a newer group of Alzheimer's treatments called anti-amyloid monoclonal antibodies. A medicine called donanemab (Kisnula) also belongs ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... Antibody-drug conjugates, such as lorvotuzumab mertansine, are ...
BJ-005 is a recombinant bifunctional molecule, composed of a humanized anti-PD-L1 IgG1 monoclonal antibody (mAb) fused with a portion of the ...
Monoclonal antibodies, such as anetumab ... Patients who have received any monoclonal antibody therapy within 4 weeks prior to entering the study.
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Eculizumab injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program called ...
Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells. Mayo Clinic Cancer Center Neuro-Oncology ...
Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.